Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Net Income Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual net income in 2023 was 546.01 Million CNY , up 178.53% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly net income in 2024 Q2 was 193.15 Million CNY , down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported an annual net income of -695.25 Million CNY in 2022, up 29.35% from previous year.
Shanghai Henlius Biotech, Inc. reported an annual net income of -984.05 Million CNY in 2021, up 5.13% from previous year.
Shanghai Henlius Biotech, Inc. reported a quarterly net income of 193.15 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported a quarterly net income of 546.01 Million CNY for 2023 FY, up 178.53% from previous quarter.

Annual Net Income Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Net Income of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Net Income	Net Income Growth
2023	546.01 Million CNY	178.53%
2022	-695.25 Million CNY	29.35%
2021	-984.05 Million CNY	5.13%
2020	-1.03 Billion CNY	-18.48%
2019	-875.46 Million CNY	-77.33%
2018	-493.68 Million CNY	-82.47%
2017	-270.56 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q1	193.15 Million CNY	39.74%
2024 Q2	193.15 Million CNY	0.0%
2023 FY	546.01 Million CNY	178.53%
2023 Q1	119.99 Million CNY	134.01%
2023 Q4	138.22 Million CNY	-17.63%
2023 Q3	167.81 Million CNY	39.86%
2023 Q2	119.99 Million CNY	0.0%
2022 Q4	-352.76 Million CNY	-290.2%
2022 Q3	-90.4 Million CNY	28.28%
2022 Q2	-126.04 Million CNY	0.0%
2022 Q1	-126.04 Million CNY	57.29%
2022 FY	-695.25 Million CNY	29.35%
2021 Q3	-295.1 Million CNY	-49.86%
2021 Q2	-196.91 Million CNY	0.0%
2021 Q1	-196.91 Million CNY	27.81%
2021 FY	-984.05 Million CNY	5.13%
2021 Q4	-295.1 Million CNY	0.0%
2020 FY	-1.03 Billion CNY	-18.48%
2020 Q4	-272.77 Million CNY	0.0%
2020 Q2	-223.99 Million CNY	0.0%
2020 Q1	-223.99 Million CNY	19.79%
2020 Q3	-272.77 Million CNY	-21.78%
2019 Q4	-279.26 Million CNY	0.0%
2019 Q2	-171.24 Million CNY	-2.5%
2019 Q1	-167.07 Million CNY	-10.64%
2019 FY	-875.46 Million CNY	-77.33%
2019 Q3	-279.26 Million CNY	-63.08%
2018 Q4	-151.01 Million CNY	0.0%
2018 FY	-493.68 Million CNY	-82.47%
2018 Q3	-151.01 Million CNY	-11.92%
2018 Q2	-134.92 Million CNY	-98.88%
2018 Q1	-67.84 Million CNY	0.0%
2017 FY	-270.56 Million CNY	0.0%

Peer Net Income Comparison of Shanghai Henlius Biotech, Inc.

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	-670.386%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	-3065.328%